Prognostic Factors for Mortality Due to Pneumonia Among Adults from Different Age Groups in Singapore and Mortality Predictions Based on PSI and CURB-65
Overview
Affiliations
Introduction: Pneumonia is associated with considerable mortality. However, there is limited information on age-specific prognostic factors for death from pneumonia.
Methods: Patients hospitalised with a diagnosis of pneumonia through the emergency department were stratified into three age groups: 18-64 years, 65-84 years and ≥ 85 years. Multivariate logistic regression and receiver operating characteristic curve analyses were conducted to evaluate prognostic factors for mortality and the performance of pneumonia severity scoring tools for mortality prediction.
Results: A total of 1,902 patients were enrolled (18-64 years: 614 [32.3%]; 65-84 years: 944 [49.6%]; ≥ 85 years: 344 [18.1%]). Mortality rates increased with age (18-64 years: 7.3%; 65-84 years: 16.1%; ≥ 85 years: 29.7%; p < 0.001). Malignancy and tachycardia were prognostic of mortality among patients aged 18-64 years. Male gender, malignancy, congestive heart failure and eight other parameters reflecting acute disease severity were associated with mortality among patients aged 65-84 years. For patients aged ≥ 85 years, altered mental status, tachycardia, blood urea nitrogen, hypoxaemia, arterial pH and pleural effusion were significantly predictive of mortality. The Pneumonia Severity Index (PSI) was more sensitive than CURB-65 (confusion, uraemia, respiratory rate ≥ 30 per minute, low blood pressure, age ≥ 65 years) for mortality prediction across all age groups.
Conclusion: The predictive effect of prognostic factors for mortality varied among patients with pneumonia from the different age groups. PSI performed significantly better than CURB-65 for mortality prediction, but its discriminative power decreased with advancing age.
Xia J, Zhuo W, Deng L, Yin S, Tang S, Yi L Oncol Lett. 2025; 29(4):191.
PMID: 40041412 PMC: 11877015. DOI: 10.3892/ol.2025.14937.
Thirawattanasoot N, Chongthanadon B, Ruangsomboon O Int J Emerg Med. 2024; 17(1):198.
PMID: 39731025 PMC: 11674152. DOI: 10.1186/s12245-024-00792-1.
Zhang J, Chou S, Wang P, Yang C, Lai Y, Chang M Front Med (Lausanne). 2024; 11:1391641.
PMID: 39234036 PMC: 11372576. DOI: 10.3389/fmed.2024.1391641.
Tuta-Quintero E, Goyes A, Guerron-Gomez G, Martinez M, Torres D, Schloss C BMC Infect Dis. 2024; 24(1):912.
PMID: 39227756 PMC: 11370103. DOI: 10.1186/s12879-024-09792-1.
Qin Q, Yu H, Zhao J, Xu X, Li Q, Gu W Front Immunol. 2024; 15:1441838.
PMID: 39114653 PMC: 11303239. DOI: 10.3389/fimmu.2024.1441838.